BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26363058)

  • 1. IL-10 Potentiates Differentiation of Human Induced Regulatory T Cells via STAT3 and Foxo1.
    Hsu P; Santner-Nanan B; Hu M; Skarratt K; Lee CH; Stormon M; Wong M; Fuller SJ; Nanan R
    J Immunol; 2015 Oct; 195(8):3665-74. PubMed ID: 26363058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural and inducible Tregs in swine: Helios expression and functional properties.
    Käser T; Mair KH; Hammer SE; Gerner W; Saalmüller A
    Dev Comp Immunol; 2015 Apr; 49(2):323-31. PubMed ID: 25511662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
    Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acid Sphingomyelinase (ASM) is a Negative Regulator of Regulatory T Cell (Treg) Development.
    Zhou Y; Salker MS; Walker B; Münzer P; Borst O; Gawaz M; Gulbins E; Singh Y; Lang F
    Cell Physiol Biochem; 2016; 39(3):985-95. PubMed ID: 27512981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
    Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
    J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Analysis of Protocols to Induce Human CD4+Foxp3+ Regulatory T Cells by Combinations of IL-2, TGF-beta, Retinoic Acid, Rapamycin and Butyrate.
    Schmidt A; Eriksson M; Shang MM; Weyd H; Tegnér J
    PLoS One; 2016; 11(2):e0148474. PubMed ID: 26886923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-12 inhibits the TGF-β-dependent T cell developmental programs and skews the TGF-β-induced differentiation into a Th1-like direction.
    Prochazkova J; Pokorna K; Holan V
    Immunobiology; 2012 Jan; 217(1):74-82. PubMed ID: 21903294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The suppressive function of human CD8(+) iTregs is inhibited by IL-1β and TNFα.
    Bjarnadottir U; Lemarquis AL; Halldorsdottir S; Freysdottir J; Ludviksson BR
    Scand J Immunol; 2014 Nov; 80(5):313-22. PubMed ID: 25039313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol.
    Schmidt A; Éliás S; Joshi RN; Tegnér J
    J Vis Exp; 2016 Dec; (118):. PubMed ID: 28060341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-10 derived from Hepatocarcinoma cells improves human induced regulatory T cells function via JAK1/STAT5 pathway in tumor microenvironment.
    Zhang S; Gan X; Qiu J; Ju Z; Gao J; Zhou J; Shi C; Zhu Y; Li Z
    Mol Immunol; 2021 May; 133():163-172. PubMed ID: 33667986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-27 inhibits the development of regulatory T cells via STAT3.
    Huber M; Steinwald V; Guralnik A; Brüstle A; Kleemann P; Rosenplänter C; Decker T; Lohoff M
    Int Immunol; 2008 Feb; 20(2):223-34. PubMed ID: 18156621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelin-reactive, TGF-β-induced regulatory T cells can be programmed to develop Th1-like effector function but remain less proinflammatory than myelin-reactive Th1 effectors and can suppress pathogenic T cell clonal expansion in vivo.
    O'Connor RA; Leech MD; Suffner J; Hämmerling GJ; Anderton SM
    J Immunol; 2010 Dec; 185(12):7235-43. PubMed ID: 21084662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralization of interleukin-10 or transforming growth factor-β decreases the percentages of CD4+ CD25+ Foxp3+ regulatory T cells in septic mice, thereby leading to an improved survival.
    Hiraki S; Ono S; Tsujimoto H; Kinoshita M; Takahata R; Miyazaki H; Saitoh D; Hase K
    Surgery; 2012 Feb; 151(2):313-22. PubMed ID: 21982068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immature dendritic cells convert anergic nonregulatory T cells into Foxp3- IL-10+ regulatory T cells by engaging CD28 and CTLA-4.
    Pletinckx K; Vaeth M; Schneider T; Beyersdorf N; Hünig T; Berberich-Siebelt F; Lutz MB
    Eur J Immunol; 2015 Feb; 45(2):480-91. PubMed ID: 25382658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells.
    Dardalhon V; Awasthi A; Kwon H; Galileos G; Gao W; Sobel RA; Mitsdoerffer M; Strom TB; Elyaman W; Ho IC; Khoury S; Oukka M; Kuchroo VK
    Nat Immunol; 2008 Dec; 9(12):1347-55. PubMed ID: 18997793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T cells in many flavors control asthma.
    Ray A; Khare A; Krishnamoorthy N; Qi Z; Ray P
    Mucosal Immunol; 2010 May; 3(3):216-29. PubMed ID: 20164832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of FoxP3 expression to identify regulatory T cells in healthy dogs and dogs with cancer.
    Biller BJ; Elmslie RE; Burnett RC; Avery AC; Dow SW
    Vet Immunol Immunopathol; 2007 Mar; 116(1-2):69-78. PubMed ID: 17224188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
    Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
    Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Akt-dependent enhanced migratory capacity of Th17 cells from children with lupus nephritis.
    Kshirsagar S; Riedl M; Billing H; Tönshoff B; Thangavadivel S; Steuber C; Staude H; Wechselberger G; Edelbauer M
    J Immunol; 2014 Nov; 193(10):4895-903. PubMed ID: 25339666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration in frequency and function of CD4⁺CD25⁺FOXP3⁺ regulatory T cells in patients with immune thrombocytopenic purpura.
    Arandi N; Mirshafiey A; Jeddi-Tehrani M; Shaghaghi M; Sadeghi B; Abolhassani H; Sharifian RA; Rahiminejad MS; Aghamohammadi A
    Iran J Allergy Asthma Immunol; 2014 Apr; 13(2):85-92. PubMed ID: 24338252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.